Regulation of adiponectin receptors in hepatocytes by the peroxisome proliferator-activated receptor-γ agonist rosiglitazone

被引：51
作者：
Sun, X [1 ]
Han, R [1 ]
Wang, Z [1 ]
Chen, Y [1 ]
机构：
[1] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai 200031, Peoples R China
来源：
DIABETOLOGIA | 2006年 / 49卷 / 06期
基金：
中国国家自然科学基金;
关键词：
adiponectin; ADIPOR1; ADIPOR2; diabetes; gene transcription; glucocorticoid receptor; obesity; peroxisome proliferator-activated receptor; receptor; rosiglitazone;
D O I：
10.1007/s00125-006-0228-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Aims/hypothesis: Adiponectin is an adipocyte-derived hormone that plays a critical role in the development of type 2 diabetes via interaction with adiponectin receptors 1 (ADIPOR1) and 2 (ADIPOR2). Rosiglitazone is a peroxisome proliferator-activated receptor-gamma (PPARG) agonist that is widely used in the treatment of type 2 diabetes. We hypothesised that rosiglitazone regulates lipid and glucose metabolism through modulation of the expression of adiponectin receptors in the liver. Methods: The expression of ADIPOR1 and ADIPOR2 was analysed in HepG2 hepatocytes. The promoters of adiponectin receptors were isolated and used to analyse the transcriptional regulation. The expression of adiponectin receptors in the liver was determined in mice treated with rosiglitazone. Results: Rosiglitazone elevated the mRNA and protein levels of ADIPOR2 and stimulated ADIPOR2 promoter in HepG2 cells. Analysis with the ADIPOR2 promoter revealed a putative rosiglitazone-responsive region that contained a glucocorticoid receptor (GR)-binding element. The GR agonist dexamethasone synergised with rosiglitazone to stimulate the ADIPOR2 promoter wheras the GR antagonist RU486 abolished this stimulation. Treatment of mice with rosiglitazone elevated the expression of ADIPOR2 in the liver. Conclusions/interpretation: This study indicates that rosiglitazone can elevate the expression of ADIPOR2 in hepatocytes. Our data also suggest that the PPARG agonist rosiglitazone can interact functionally with a GR element in the ADIPOR2 promoter to mediate stimulation of transcription. This study thus reveals a new paradigm underlying the therapeutic effect of PPARG activators in the treatment of type 2 diabetes.
引用
收藏
页码：1303 / 1310
页数：8
相关论文
共 33 条
[1]   The mechanisms of action of PPARs [J].
Berger, J ;
Moller, DE .
ANNUAL REVIEW OF MEDICINE, 2002, 53 :409-435
[2]   Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPARα, PPARγ, and LXR [J].
Chinetti, G ;
Zawadski, C ;
Fruchart, JC ;
Staels, B .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 314 (01) :151-158
[3]   Adiponectin receptors gene expression and insulin sensitivity in non-diabetic Mexican Americans with or without a family history of Type 2 diabetes [J].
Civitarese, AE ;
Jenkinson, CP ;
Richardson, D ;
Bajaj, M ;
Cusi, K ;
Kashyap, S ;
Berria, R ;
Belfort, R ;
DeFronzo, RA ;
Mandarino, LJ ;
Ravussin, E .
DIABETOLOGIA, 2004, 47 (05) :816-820
[4]   Genetic variation in adiponectin receptor 1 and adiponectin receptor 2 is associated with type 2 diabetes in the old order amish [J].
Damcott, CM ;
Ott, SH ;
Pollin, TI ;
Reinhart, LJ ;
Wang, M ;
O'Connell, JR ;
Mitchell, BD ;
Shuldiner, AR .
DIABETES, 2005, 54 (07) :2245-2250
[5]   Be fit or be sick: Peroxisome proliferator-activated receptors are down the road [J].
Desvergne, B ;
Michalik, L ;
Wahli, W .
MOLECULAR ENDOCRINOLOGY, 2004, 18 (06) :1321-1332
[6]   Growth hormone is a positive regulator of adiponectin receptor 2 in 3T3-L1 adipocytes [J].
Fasshauer, M ;
Klein, J ;
Kralisch, S ;
Klier, M ;
Lössner, U ;
Blüher, M ;
Paschke, R .
FEBS LETTERS, 2004, 558 (1-3) :27-32
[7]   Improved packing of poly(ethylenimine)/DNA complexes increases transfection efficiency [J].
Godbey, WT ;
Ku, KK ;
Hirasaki, GJ ;
Mikos, AG .
GENE THERAPY, 1999, 6 (08) :1380-1388
[8]   AdipoQ is a novel adipose-specific gene dysregulated in obesity [J].
Hu, E ;
Liang, P ;
Spiegelman, BM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (18) :10697-10703
[9]   T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin [J].
Hug, C ;
Wang, J ;
Ahmad, NS ;
Bogan, JS ;
Tsao, TS ;
Lodish, HF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (28) :10308-10313
[10]   Mechanism of the anti-inflammatory effect of thiazolidinediones: Relationship with the glucocorticoid pathway [J].
Ialenti, A ;
Grassia, G ;
Di Meglio, P ;
Maffia, P ;
Di Rosa, M ;
Ianaro, A .
MOLECULAR PHARMACOLOGY, 2005, 67 (05) :1620-1628
1234